Classification of immune profiling on tumor samples helps explain improving treatment outcomes, paving the way for ...

Bcl6 regulates the lineage stability and suppressive function of Treg cells in head and neck squamous cell carcinoma ...

“Introducing Shirley Chung 2.0 !!,” the post says. “11 months ago, May 30th 2024, I was diagnosed with stage 4 squamous cell carcinoma tongue cancer. The tumor was hidden on the bottom left of my ...

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China bGuangdong Esophageal Cancer ...

Chung, 48, was diagnosed with stage 4 squamous cell carcinoma tongue cancer. on May 30, 2024. After deciding not to undergo surgery to remove her tongue, she moved to Chicago and began radiation and ...

1Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, ...

Global incidence of tongue squamous cell carcinoma (TSCC) has been steadily increasing. Our previous studies have demonstrated that capsaicin (CAP) can promote apoptosis and inhibit cell migration, ...

Copyright: © 2019 Elsevier Ltd. All rights reserved.

The VENTANA MET (SP44) RxDx Assay detects the MET (also known as c-Met) protein, which is over-expressed in some patients with non-squamous non-small cell lung cancer (NSQ-NSCLC). The MET protein ...